279 related articles for article (PubMed ID: 23557078)
1. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.
Kahrilas PJ; Howden CW; Wernersson B; Denison H; Nuevo J; Gisbert JP
Aliment Pharmacol Ther; 2013 May; 37(10):1005-10. PubMed ID: 23557078
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Kindt S; Imschoot J; Tack J
Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
[TBL] [Abstract][Full Text] [Related]
3. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
4. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):612-9. PubMed ID: 22343515
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
Eloubeidi MA; Provenzale D
Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
[TBL] [Abstract][Full Text] [Related]
7. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
[TBL] [Abstract][Full Text] [Related]
8. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity.
Dubois RW; Aguilar D; Fass R; Orr WC; Elfant AB; Dean BB; Harper AS; Yu HT; Melmed GY; Lynn R; Singh A; Tedeschi M
Aliment Pharmacol Ther; 2007 Feb; 25(4):487-500. PubMed ID: 17270005
[TBL] [Abstract][Full Text] [Related]
9. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
10. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Gut; 2014 May; 63(5):720-6. PubMed ID: 23831734
[TBL] [Abstract][Full Text] [Related]
11. Airway symptoms and sleeping difficulties in operated and non-operated patients with gastroesophageal reflux disease.
Johannessen R; Petersen H; Olberg P; Johnsen G; Fjøsne U; Kleveland PM
Scand J Gastroenterol; 2012 Jul; 47(7):762-9. PubMed ID: 22571295
[TBL] [Abstract][Full Text] [Related]
12. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
[TBL] [Abstract][Full Text] [Related]
13. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
Wahlqvist P; Carlsson J; Stålhammar NO; Wiklund I
Value Health; 2002; 5(2):106-13. PubMed ID: 11918826
[TBL] [Abstract][Full Text] [Related]
14. Night-time and daytime atypical manifestations of gastro-oesophageal reflux disease: frequency, severity and impact on health-related quality of life.
Dean BB; Aguilar D; Johnson LF; McGuigan JE; Orr WC; Fass R; Yan N; Morgenstern D; Dubois RW
Aliment Pharmacol Ther; 2008 Feb; 27(4):327-37. PubMed ID: 18005248
[TBL] [Abstract][Full Text] [Related]
15. Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany.
Madisch A; Kulich KR; Malfertheiner P; Ziegler K; Bayerdörffer E; Miehlke S; Labenz J; Carlsson J; Wiklund IK
Z Gastroenterol; 2003 Dec; 41(12):1137-43. PubMed ID: 14661122
[TBL] [Abstract][Full Text] [Related]
16. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
17. [Burden of illness in Polish patients with reflux disease].
Reguła J; Kulich KR; Stasiewicz J; Jasiński B; Carlsson J; Wiklund I
Przegl Epidemiol; 2005; 59(1):75-85. PubMed ID: 16013413
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
19. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
Chand N; Johnson DA; Tabangin M; Ware JC
Aliment Pharmacol Ther; 2004 Nov; 20(9):969-74. PubMed ID: 15521844
[TBL] [Abstract][Full Text] [Related]
20. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
